Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells.
Linder SJ, Bernasocchi T, Martínez-Pastor B, Sullivan KD, Galbraith MD, Lewis CA, Ferrer CM, Boon R, Silveira GG, Cho HM, Vidoudez C, Shroff S, Oliveira-Costa JP, Ross KN, Massri R, Matoba Y, Kim E, Rueda BR, Stott SL, Gottlieb E, Espinosa JM, Mostoslavsky R. Linder SJ, et al. Among authors: matoba y. Nat Metab. 2023 Dec;5(12):2131-2147. doi: 10.1038/s42255-023-00919-3. Epub 2023 Nov 13. Nat Metab. 2023. PMID: 37957387
Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma.
Matoba Y, Zarrella DT, Pooladanda V, Azimi Mohammadabadi M, Kim E, Kumar S, Xu M, Qin X, Ray LJ, Devins KM, Kumar R, Kononenko A, Eisenhauer E, Veillard IE, Yamagami W, Hill SJ, Sarosiek KA, Yeku OO, Spriggs DR, Rueda BR. Matoba Y, et al. Br J Cancer. 2024 May;130(9):1463-1476. doi: 10.1038/s41416-024-02621-x. Epub 2024 Mar 4. Br J Cancer. 2024. PMID: 38438589 Free PMC article.
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer.
Kobayashi Y, Kashima H, Rahmanto YS, Banno K, Yu Y, Matoba Y, Watanabe K, Iijima M, Takeda T, Kunitomi H, Iida M, Adachi M, Nakamura K, Tsuji K, Masuda K, Nomura H, Tominaga E, Aoki D. Kobayashi Y, et al. Among authors: matoba y. Oncotarget. 2017 Aug 7;8(42):72147-72156. doi: 10.18632/oncotarget.20046. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069775 Free PMC article.
Aversion to a High Salt Taste is Disturbed in Patients With CKD.
Okuno-Ozeki N, Kohama Y, Taguchi H, Kawate Y, Umehara M, Minamida A, Yamauchi-Sawada H, Sunahara Y, Matoba Y, Nakamura I, Nakai K, Nakata T, Kirita Y, Taniguchi T, Tamagaki K, Hirao T, Matoba S, Kusaba T. Okuno-Ozeki N, et al. Among authors: matoba y. Kidney Int Rep. 2024 Feb 16;9(5):1254-1264. doi: 10.1016/j.ekir.2024.02.1393. eCollection 2024 May. Kidney Int Rep. 2024. PMID: 38707820 Free PMC article.
The importance of proinflammatory failed-repair tubular epithelia as a predictor of diabetic kidney disease progression.
Tomita-Yagi A, Ozeki-Okuno N, Watanabe-Uehara N, Komaki K, Umehara M, Sawada-Yamauchi H, Minamida A, Sunahara Y, Matoba Y, Nakamura I, Nakata T, Nakai K, Ida T, Yamashita N, Kamezaki M, Kirita Y, Taniguchi T, Konishi E, Matoba S, Tamagaki K, Kusaba T. Tomita-Yagi A, et al. Among authors: matoba y. iScience. 2024 Jan 26;27(2):109020. doi: 10.1016/j.isci.2024.109020. eCollection 2024 Feb 16. iScience. 2024. PMID: 38357667 Free PMC article.
Possible Relationship between the Deteriorated Accuracy of Intermittent-Scanning Continuous Glucose Monitoring Device and the Contact Dermatitis: Post-hoc analysis of the ISCHIA Study.
Toyoda M, Murata T, Hirota Y, Hosoda K, Kato K, Kouyama K, Kouyama R, Kuroda A, Matoba Y, Matsuhisa M, Meguro S, Miura J, Nishimura K, Shimada A, Suzuki S, Tone A, Sakane N; ISCHIA Study Group. Toyoda M, et al. Among authors: matoba y. Tokai J Exp Clin Med. 2023 Sep 20;48(3):83-90. Tokai J Exp Clin Med. 2023. PMID: 37635068 Free article. Clinical Trial.
246 results